Symposia

The following are the five symposia taking place at CAEP 2016.

Safety in Numbers (Breakfast - Sunday June 5)

Safety in Numbers

Date:  Sunday June 5, 2016
Time: 7:00 AM – 8:15 AM
Location: Hilton Québec

ED Management of AF and PE: Preventing Death and Disability.

A Case based approach to managing AF and PE in the Emergency Department.  As well the presentation will review the current clinical tools for real-time ED decision support to assist with anticoagulation treatment and bleed management

Presented by Dr. Anil Chopra.

Learning Objectives:

After attending this symposium, participants should be able to:

  • Discuss evidence-based management of ED patients with AF
  • Discuss clinical tools for real-time ED decision support to assist with anticoagulation treatment and bleed management

NOAC, Interrupted: New Options for Emergency Care (Breakfast - Monday June 6)

NOAC, Interrupted:  New Options for Emergency Care

Date:  Monday June 6, 2016
Time:
7:00 AM – 8:15 AM
Location:
Hilton Québec

While the advent of novel oral anticoagulants (NOACs) has decreased incidences of major bleeding compared to warfarin 1-4, the lack of a direct reversal agent has remained a barrier to use for some physicians.

Anticoagulant reversal agents will soon be entering emergency rooms across the country, providing another tool for physicians in the emergency care setting. This case-based symposium will provide practical tips and tools for situation in which anticoagulant reversal agents should be used in emergency care.

Presented by Dr. Eddy Lang, Dr. Rob Green & Dr. Adam Dukelow.

Learning Objectives:

After attending this symposium, participants should be able to:

  • Improve the awareness and understanding of novel anticoagulant reversal agents in the emergency care settings
  • Identify key clinical case settings where reversal of anticoagulation is needed
  • Explore practical issues related to initiation of anticoagulation reversal agents for emergency care settings

Breaking News Alert: Outbreaks of Boils (Breakfast - Tuesday June 7)

Breaking News Alert:  Outbreaks of Boils

Date: Tuesday June 7, 2016
Time:
7:00 AM – 8:15 AM
Location:
Hilton Québec

Come to learn on novel evidence-based approaches in recognition of Hidradenitis Suppurativa (HS) that are taking place and why you should be part of it!  Elevate your disease recognition and ensure optimal referral to a dermatologist to improve patient outcome. What can go wrong? Why you should not refer to a surgeon! And top 3 things to remember about HS!

Presented by Dr. Philippe Grant, Dr. Neil Shear & Dr. Ralph George.

Learning Objectives:

After attending this symposium, participants should be able to:

  • Raise awareness around the clinical presentation, diagnosis and treatment options for HS in an emergency room
  • Address the barriers that may prevent some physicians from diagnosing and treating HS
  • Review practical aspects to ensure rapid referral to a dermatologist or a surgeon
  • Respond appropriately to the HS reality lived by people living with the disease

Managing AF and VTE: a DOAC at a time (Lunch - Tuesday June 7)

Managing AF and VTE:  a DOAC at a Time

Date:  Tuesday June 7, 2016
Time:
12:00 PM – 1:15 PM
Location:
Hilton Québec

Managing AF and VTE: a DOAC at a time, is a program targeted at Emergency Room (ER) physicians, exploring the use of anti-thrombotic agents in the management of Atrial Fibrillation (AF) and Venous Thromboembolism (VTE). There are crucial challenges being faced in the ER with regards to disease assessment and treatment initiation, notably with regards to agent and dose selection and urgency of timing. By presenting real world data and clinical based evidence, this program aims to aid in promoting disease management and stroke prevention as well as describing complex clinical cases encountered in the chaotic ER setting.

Presented by Dr. Anas Nseir, Dr. James Douketis, & Dr. Indraneel Ghosh.

Learning Objectives:

After attending this symposium, participants should be able to:

  • Integrate real-world evidence when considering the use of DOACs in patients with AF.
  • Provide evidence-based care to patients with challenging cases of VTE presenting in the ER.
  • Drive the use of antithrombotic agents for stroke prevention in AF and VTE.

What Every Emergency Physician Needs to Know about the Management of Adverse Events Associated with New Cancer Immunotherapies (Breakfast - Wednesday June 8)

What Every Emergency Physician Needs to Know about the Management of Adverse Events Associated with New Cancer Immunotherapies

Date:  Wednesday June 8, 2016
Time:
7:00 AM – 8:15 AM
Location:
Hilton Québec

Immune checkpoint inhibitors represent an exciting development in the treatment of metastatic melanoma, lung cancer, renal cancer, and other cancers, particularly with the introduction of PD-1 inhibitors. Cell therapies have also shown significant benefit in patients with hematologic malignancies.  The progression-free survival and overall survival of patients treated with these agents is significantly prolonged relative to chemotherapy. Immune checkpoint inhibition is also associated with immune-related adverse events (irAEs), which differ significantly from those caused by chemotherapy. Clinicians need to have a high degree of vigilance in order to recognize irAEs in a timely manner and need to be aware of the treatment algorithms for the management of irAEs in order to avoid serious complications. Emergency physicians will be encountering patients whose treatment includes immunotherapy and thus knowledge of irAEs is essential.

Presented by Dr. Marcus Butler.

Learning Objectives:

After attending this symposium, participants should be able to:

  • Explain the impact of immunotherapy on the treatment of cancer
  • Identify the spectrum of immune-related adverse events (AEs) associated with cancer immunotherapy
  • Describe the clinical approach to immune-related AE management
  • Highlight the need for strong relationships between emergency physicians and medical oncologists within institutions served by your region